Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Small oral and topical studies reported modest changes in some pigmentation measurements
Crizanlizumab for the prevention of pain crises in sickle cell disease
Czechia 99.7 % purity confirmed by COA Assay content verified at 12.24 mg Identification confirmed by FTIR and retention time analysis Molecular ion mass identified at 848 Da Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination DSIP peptide research compound For research use only not for human or veterinary use For laboratory research only
Cavazzana-Calvo, M
US$ 29.80
US$ 29.04
US$ 25.47
US$ 28.29
US$ 24.11
